Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,390 articles

Articles by Daniel Marsh

T1 Energy Hits Record High Amid AI Data Center Hype; Uncertainties Loom
Markets

T1 Energy Hits Record High Amid AI Data Center Hype; Uncertainties Loom

T1 Energy shares hit a record high of $12.18 on AI data center demand and strong Q1 results, but risks including single-customer reliance and financing challenges remain.

Rivian R2 Launch Fuels Stock Rally as Key Test Nears
Markets

Rivian R2 Launch Fuels Stock Rally as Key Test Nears

Rivian shares gained 2.3% to $17.34 as investors anticipate the June 9 R2 launch, marking the EV maker's first major market test for its lower-priced SUV line.

RIVN TSLA LCID
Redwire's Rally Stalls as Jefferies Downgrades on Valuation Concerns
Markets

Redwire's Rally Stalls as Jefferies Downgrades on Valuation Concerns

Redwire shares rose 0.7% after Jefferies downgraded to Hold, warning the stock's 223% YTD rally has outpaced fundamentals. Backlog hit a record $498.1M, but risks remain.

RDW
BlackBerry Hits New 52-Week High on QNX Momentum and Buyback
Markets

BlackBerry Hits New 52-Week High on QNX Momentum and Buyback

BlackBerry shares hit a 52-week high of $10.26, up 4.2%, on QNX robotics momentum, FedRAMP recertification, and a renewed buyback. The stock's $2.1B market cap jump faces a key test at June 25 earnings.

BB
GPUS Surges 46% on Bitcoin Treasury and Buyback News
Markets

GPUS Surges 46% on Bitcoin Treasury and Buyback News

Hyperscale Data Inc. shares soared 46% after a $5M buyback and Bitcoin treasury update, but a filing warns of up to 43M new shares from convertible notes.

GPUS
Oklo Stock Surges on Nuclear Fuel Hopes and DOE Milestones
Markets

Oklo Stock Surges on Nuclear Fuel Hopes and DOE Milestones

Oklo shares surged 8% amid DOE plutonium fuel talks and a July reactor pilot deadline, as investors eye advanced nuclear growth from AI and data centers.

OKLO SMR META NUE
Keel Infrastructure Breaks $6 as AI Power Push Intensifies
Markets

Keel Infrastructure Breaks $6 as AI Power Push Intensifies

Keel Infrastructure Corp. (KEEL) jumps 2.29% to $6.24 on heavy volume, driven by its pivot to AI data-center power and a 2.2 GW pipeline, despite Q1 revenue drop and net loss.

Milbank Sets New Big Law Salary Benchmark at $455K; Rivals Quickly Follow
Analysis

Milbank Sets New Big Law Salary Benchmark at $455K; Rivals Quickly Follow

Milbank LLP has increased associate pay to $455,000, prompting immediate responses from rivals like McDermott Will & Schulte and reigniting salary competition among top U.S. law firms.

FuelCell Energy Shares Jump 14% Ahead of Earnings, Options Signal Big Swing
Markets

FuelCell Energy Shares Jump 14% Ahead of Earnings, Options Signal Big Swing

FuelCell Energy shares jumped 14% to $24.31 ahead of June 8 earnings, with options pricing a 17% swing. The rally is fueled by AI data-center power demand, but a 10.8% backlog drop and ongoing losses add risk.

FCEL BE PLUG
Opendoor Surges on Russell 3000 Index Inclusion Anticipation
Markets

Opendoor Surges on Russell 3000 Index Inclusion Anticipation

Opendoor Technologies climbed 4.9% to $5.57 as investors anticipate its addition to the Russell 3000 Index, driving heavy trading volume and index-related flows.

OPEN ZG COMP IWM
NuScale Power Jumps 8.6% as Nuclear AI Trade Resurfaces
Markets

NuScale Power Jumps 8.6% as Nuclear AI Trade Resurfaces

NuScale Power shares rose 8.6% to $14.00 Tuesday amid renewed investor interest in nuclear energy for AI and data centers, though the company reported only $565,000 in Q1 revenue and faces risks without binding contracts.

SMR OKLO CEG
Bluejay Diagnostics Stock Surges 171% on U.S. Manufacturing Deal, FDA Hurdle Remains
Markets

Bluejay Diagnostics Stock Surges 171% on U.S. Manufacturing Deal, FDA Hurdle Remains

Bluejay Diagnostics shares surged 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, but the stock faces risks from pending FDA clearance and ongoing capital needs.